Devices and methods for protecting against neuromas

Patent metadata

Field	Value
Publication number	US-2021161611-A1
Application number	US-202117173004-A
Country	US
Kind code	A1
Filing date	Feb 10, 2021
Priority date	Sep 25, 2012
Publication date	Jun 3, 2021
Grant date	—

Abstract

The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). Tabs arranged on the outside of the cap can be used to manipulate the cap into place on a nerve. The open end can also be configured with flaps that can be used to widen the open end for easier insertion of the nerve into the cap. In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.

First claim

1 - 20 . (canceled)

21 . A device comprising:
a body having an open proximal end and a closed distal end, wherein the open proximal end is the only opening in the body; and an internal chamber defined by the body, wherein the internal chamber is physically partitioned, wherein the body of the device is about 1 mm to about 500 mm in length.

22 . The device of claim 21 , further comprising a biomaterial configured to remodel into a tissue cushion after implantation of the device.

23 . The device of claim 21 , wherein the body of the device is about 1 mm to about 100 mm in diameter.

24 . The device of claim 21 , wherein the body of the device is about 1 mm to about 100 mm in length.

25 . The device of claim 24 , wherein the body of the device is about 1 mm to about 25 mm in diameter.

26 . The device of claim 21 , wherein the body has a diameter at a distal end region that is less than a diameter at a proximal end region.

27 . The device of claim 21 , wherein the body has a diameter at a distal end region that is approximately equal to a diameter at a proximal end region.

28 . The device of claim 21 , wherein an interior surface of the closed distal end is beveled, conical, or flat.

29 . The device of claim 21 , wherein the device comprises a biomaterial selected from the group consisting of: high-density polyethylene (HDPE), polyethylene glycol (PEG) hydrogel, purified protein from human or animal sources, and decellularized tissue constructs.

30 . The device of claim 29 , wherein the biomaterial is selected from the group consisting of: collagen, fibrin, demineralized bone, amnion, small intestine submucosa (SIS), dermis, or fascia.

31 . The device of claim 29 , wherein the device comprises porous HDPE or PEG surrounded by a layer of non-porous HDPE or PEG.

32 . The device of claim 21 , wherein the body is cylindrical in shape.

33 . A method of using the device of claim 21 , comprising inserting a nerve stump into the proximal end of the device.

34 . The method of claim 33 , wherein a neuroma formed out of the inserted nerve stump is protected from external stimuli.

35 . The method of claim 33 , wherein nerve outgrowth that forms from the inserted nerve stump is separated within the internal chamber of the device after implantation of the device.

36 . A method for preventing or limiting neuroma formation comprising inserting and securing a nerve stump into the device of claim 21 .

37 . The method of claim 36 , wherein the nerve stump is secured into the device using one or more of a suture, a staple, a clip, or a surgical adhesive or sealant.

38 . The method of claim 36 , wherein neuroma formation is limited as compared to neuroma formation without the device.

39 . A method comprising:
inserting and securing a nerve stump into the device of claim 21 to decrease pain associated with a neuroma formation as compared to pain associated with a neuroma formation without the device.

40 . The method of claim 39 , wherein the nerve stump is secured into the device using one or more of a suture, a staple, a clip, or a surgical adhesive or sealant.

Assignees

• Axogen Corp

Inventors

• Deister Curt
• Simon Crystal
• Faleris Jennifer

Classifications

• A61L31/04 Primary

  Macromolecular materials · CPC title

• A61L27/3675

  Nerve tissue, e.g. brain, spinal cord, nerves, dura mater · CPC title

• A61L31/06

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

• A61L31/048

  obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence) · CPC title

• A61L31/005

  Ingredients of undetermined constitution or reaction products thereof · CPC title